These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33217633)

  • 41. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues.
    Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O
    Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
    Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N
    Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tubulin inhibitory activity of a novel colchicine-binding compounds based on a dinaphthospiropyranran scaffold.
    Sundriyal S; Eeda V; Lagisetty P; Awasthi V
    Bioorg Med Chem; 2021 Jan; 29():115874. PubMed ID: 33223461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
    Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
    Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
    Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
    ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
    Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK
    Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production.
    Tang H; Liang Y; Cheng J; Ding K; Wang Y
    Eur J Med Chem; 2021 Oct; 221():113531. PubMed ID: 34044345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of substituted biphenyl methylene indolinones as apoptosis inducers and tubulin polymerization inhibitors.
    Donthiboina K; Anchi P; Sri Ramya PV; Karri S; Srinivasulu G; Godugu C; Shankaraiah N; Kamal A
    Bioorg Chem; 2019 May; 86():210-223. PubMed ID: 30716619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological Evaluation of Aldehydic-Pyrrolidinedione Against HCT-116, MDA-MB231, NIH/3T3, MCF-7 Cancer Cell Lines, Antioxidant and Enzyme Inhibition Studies.
    Ahmad A; Ullah F; Sadiq A; Ayaz M; Rahim H; Rashid U; Ahmad S; Jan MS; Ullah R; Shahat AA; Mahmood HM
    Drug Des Devel Ther; 2019; 13():4185-4194. PubMed ID: 31849450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
    Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
    Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
    Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, antiproliferative activity, and molecular docking studies of 4-chlorothiocolchicine analogues.
    Klejborowska G; Moshari M; Maj E; Majcher U; Preto J; Wietrzyk J; Tuszynski JA; Huczyński A
    Chem Biol Drug Des; 2020 Jan; 95(1):182-191. PubMed ID: 31483093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.
    Zhang YL; Li BY; Yang R; Xia LY; Fan AL; Chu YC; Wang LJ; Wang ZC; Jiang AQ; Zhu HL
    Eur J Med Chem; 2019 Feb; 163():896-910. PubMed ID: 30580241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and broad spectrum antibreast cancer activity of diarylindoles via induction of apoptosis in aggressive breast cancer cells.
    Gautam Y; Das S; Khan H; Pathak N; Iqbal H; Yadav P; Sirohi VK; Khan S; Raghuvanshi DS; Dwivedi A; Chanda D; Shanker K; Khan F; Konwar R; Negi AS
    Bioorg Med Chem; 2021 Jul; 42():116252. PubMed ID: 34153643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
    Shao YY; Yin Y; Lian BP; Leng JF; Xia YZ; Kong LY
    Eur J Med Chem; 2020 Mar; 190():112105. PubMed ID: 32035399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
    Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
    Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors.
    Donthiboina K; Anchi P; Gurram S; Sai Mani G; Lakshmi Uppu J; Godugu C; Shankaraiah N; Kamal A
    Bioorg Chem; 2020 Oct; 103():104191. PubMed ID: 32891862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.